励晶太平洋(00575)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00575 励晶太平洋

开市前 09-11 09:07:04

0.845

+0.000

0.00%

最高0.845	最低0.845	成交量0.00
今开0.845	昨收0.845	日振幅0.00%
总市值2.47亿	流通市值2.47亿	总股本2.92亿
成交额0.00	换手率0.00%	流通股本2.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00575","market":"HK","secType":"STK","nameCN":"励晶太平洋","latestPrice":0.845,"timestamp":1789088401001,"preClose":0.845,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":292000000,"shares":292000000,"eps":-0.14115654260574978,"marketStatus":"开市前","change":0,"latestTime":"09-11 09:07:04","open":0.845,"high":0.845,"low":0.845,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0.785,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":-0.05231418309571982,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":1,"adr":0,"listingDate":863971200000,"exchange":"SEHK","adjPreClose":0.845,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":0,"lotSize":10000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00575","defaultTab":"news","newsList":[{"id":"2664566808","title":"励晶太平洋(00575)已收取来自复星的里程碑款项净额450万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664566808","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664566808?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:55","pubTimestamp":1788263706,"startTime":"0","endTime":"0","summary":"智通财经APP讯，励晶太平洋 发布公告，于2026年8月31日，根据集团与复星万邦(江苏)医药集团有限公司(复星)就Senstend于中国的授权及合作安排，集团已收取来自复星扣除中国预扣税后的里程碑款项净额450万美元，进一步彰显该战略合作伙伴关系的持续实力与价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124538969","title":"励晶太平洋（00575）获4,500,000美元里程碑款　加速推进Senstend™在华商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1124538969","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124538969?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:52","pubTimestamp":1788263541,"startTime":"0","endTime":"0","summary":"2026年9月1日，励晶太平洋集团有限公司发布自愿性营运情况更新。\\n\\n该款项源于双方在中国市场推广男性早泄治疗药物Senstend的合作协议。根据协议条款，在Senstend实现首次商业化后，励晶太平洋将另行获得扣除中国预扣税后的1,800,000美元。\\n\\n未来，如Senstend在中国的年度净销售额达到既定门槛，励晶太平洋可获得总计最高25,000,000美元的额外商业里程碑款项。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125941875","title":"励晶太平洋2026年8月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1125941875","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125941875?lang=zh_cn&edition=full","pubTime":"2026-09-01 18:46","pubTimestamp":1788259593,"startTime":"0","endTime":"0","summary":"励晶太平洋集团有限公司于2026年9月1日发布截至2026年8月31日的月度股份变动月报。报告显示，截至8月底，公司已发行且不含库存的普通股数量为291,815,782股，与上月底持平；库存股份为0股。在股份激励方面，公司“购股权计划”剩余的可行使购股权数量为6,229,723份，当月未有增减，也未因行权新增发行股份或转让库存股份。本月内未发生任何股份发行、回购或注销等变动；公司总股本维持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662321787","title":"励晶太平洋(00575)公布中期业绩 净利54.4万美元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2662321787","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662321787?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:46","pubTimestamp":1787661967,"startTime":"0","endTime":"0","summary":"智通财经APP讯，励晶太平洋(00575)公布2026年中期业绩，收益527.5万美元，同比增长约21.26倍;净利54.4万美元，同比扭亏为盈;每股盈利0.186美仙。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485392.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"励晶太平洋(00575)公布中期业绩 净利54.4万美元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128603297","title":"励晶太平洋(00575)公布2026年中期业绩：获500万美元里程碑款推动期内扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1128603297","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128603297?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:36","pubTimestamp":1787661380,"startTime":"0","endTime":"0","summary":"励晶太平洋集团有限公司8月25日披露截至2026年6月30日止六个月未经审计中期业绩。期内，集团实现收益5,275,000美元，同比增加2,126%，主要来自Senstend在中国获批后复星万邦支付的里程碑款500万美元（扣税前）。受此带动，集团录得净利润544,000美元，去年同期为净亏损2,215,000美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179110255","title":"励晶太平洋（00575）将于8月25日审议2026年中期业绩及派息计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1179110255","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179110255?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:40","pubTimestamp":1786610449,"startTime":"0","endTime":"0","summary":"励晶太平洋集团有限公司8月13日公告称，董事会已订于2026年8月25日（星期二）召开会议，届时将审议并批准集团截至2026年6月30日止六个月的中期业绩及其发布事宜，并考虑派付中期股息（如有）。\\n\\n公司董事会目前由6名董事组成，其中执行董事1名，非执行董事2名，独立非执行董事3名。公告同时提示，香港交易及结算所有限公司及香港联合交易所有限公司概不对公告内容的准确性或完整性承担任何责任。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126088891","title":"励晶太平洋（00575）发布正面盈利预告 预计2026年上半年扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1126088891","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126088891?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:19","pubTimestamp":1785748748,"startTime":"0","endTime":"0","summary":"2026年8月3日，励晶太平洋集团有限公司在港交所公告，预计截至2026年6月30日止六个月将录得500,000至1,000,000美元的溢利，而去年同期则录得约2,220,000美元的亏损。励晶太平洋计划于2026年8月底前发布未经审核的中期业绩公告。公司提醒投资者在买卖公司股份时保持审慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656532291","title":"励晶太平洋(00575)发盈喜 预计上半年溢利约50万至100万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656532291","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656532291?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:12","pubTimestamp":1785748374,"startTime":"0","endTime":"0","summary":"智通财经APP讯，励晶太平洋 发布公告，集团预期于截至2026年6月30日止期间将取得介于约50万美元至约100万美元的溢利，与截至2025年相应期间约222万美元的亏损比较，反映显著改善。构成报告期间的溢利的所有其他项目与相应期间的项目基本相符。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107651594","title":"励晶太平洋7月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1107651594","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107651594?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:58","pubTimestamp":1785747522,"startTime":"0","endTime":"0","summary":"励晶太平洋于2026年8月3日发布2026年7月股份变动月报表。报告显示，截至2026年7月31日，公司已发行普通股数量为291,815,782股，较上月底无增减变动，库存股份数为0股，股本总体保持稳定。根据公告披露，公司法定/注册股本由143,000,000,000股普通股和550,000,000股未分类股份组成，均为每股面值0.001美元，对应法定/注册股本分别为143,000,000美元和550,000美元，总额143,550,000美元。公告期内，上述法定/注册股本无增减变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196737365","title":"励晶太平洋（00575）补充披露：2025年预付款项等应收款减少22.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196737365","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196737365?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:35","pubTimestamp":1783589733,"startTime":"0","endTime":"0","summary":"2026年7月9日，励晶太平洋集团有限公司发布公告，对其2025年年报中“管理层对本集团业绩之讨论及分析”章节的部分内容作出补充说明。公司披露，截至2025年12月31日，集团的预付款项、按金及其他应收款项约为285,000美元，较2024年12月31日的约369,000美元减少约22.76%。公告指出，上述减幅主要源于一笔约80,000美元的一次性报销款项已于2025年3月全部结付。公司表示，上述补充资料仅对2025年年报中相关信息进行补充，不影响年报其他内容。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189644725","title":"励晶太平洋6月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1189644725","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189644725?lang=zh_cn&edition=full","pubTime":"2026-07-03 17:50","pubTimestamp":1783072229,"startTime":"0","endTime":"0","summary":"励晶太平洋集团有限公司于2026年7月3日发布截至2026年6月30日的股份变动月报表。公告显示，公司本月未出现新发行、回购或注销股份活动，整体股本保持稳定。本月末公司法定股本合计143,550,000美元，较上月底无变化。已发行股份方面，截至6月末，励晶太平洋已发行普通股总数为291,815,782股，与上月底持平。公司明确声明已遵守香港联合交易所有限公司《上市规则》及相关法律法规要求。该月报表由公司秘书雷美欣根据董事会授权签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536819","title":"励晶太平洋(00575)：新经同行评审研究发现Deep Longevity的以血液为基础的生物年龄差距可预测死亡率及住院风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536819","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647536819?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:36","pubTimestamp":1782808567,"startTime":"0","endTime":"0","summary":"智通财经APP讯，励晶太平洋 发布公告，于《衰老与疾病》发表的研究显示，Deep Longevity之 BloodAge模型应用于一项历时近十年、涵盖超过2500名成人的研究中，识别出一种可量化的“年龄差距”，该差距与显著较高的死亡及住院风险相关。研究人员使用Deep Longevity的SenoClock平台所提供的BloodAge模型，从涵盖代谢、肝脏、肾脏、血液及发炎功能的36项常规血液生物标记中，估算每位参与者的生物年龄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646875901","title":"励晶太平洋(00575.HK)：Deep Longevity荣获Nestlé VITAL智能老化全球挑战赛亚军","url":"https://stock-news.laohu8.com/highlight/detail?id=2646875901","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646875901?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:07","pubTimestamp":1782378461,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644182357","title":"港股异动 | 励晶太平洋(00575)一度飙升110% 旗下创新药Senstend™获国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2644182357","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644182357?lang=zh_cn&edition=full","pubTime":"2026-06-17 13:55","pubTimestamp":1781675740,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，励晶太平洋今日一度飙涨超110% ，截至发稿，涨80.7%，报1.03港元，成交额264.96万港元。消息面上，励晶太平洋宣布，旗下创新疗法 Senstend 的新药申请已正式获得国家药品监督管理局的上市批准，并附带为期四年数据保护期。此外，随着江苏万邦医药预计将于2026年下半年启动首次商业销售，届时将再度触发向励晶太平洋支付200万美元。因此，集团预计将于2026年内稳健收取合共700万美元的现金付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","06978","BK1574","BK4588","IPOS","BK4585","00575","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190956774","title":"励晶太平洋预期实现年净销售额等目标后，商业里程碑与特许权使用费合计可达2500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190956774","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190956774?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:39","pubTimestamp":1781606372,"startTime":"0","endTime":"0","summary":"励晶太平洋预计，在达成年度净销售额及其他相关目标后，其商业里程碑付款与特许权使用费总额最高可达2500万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115544475","title":"励晶太平洋集团预计2026年将获得江苏万邦生物医药里程碑付款700万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115544475","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115544475?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:39","pubTimestamp":1781606365,"startTime":"0","endTime":"0","summary":"励晶太平洋集团宣布，预计将在2026年从江苏万邦生物医药有限公司获得总计700万美元的里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133535743","title":"励晶太平洋更新5月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1133535743","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133535743?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:31","pubTimestamp":1780392661,"startTime":"0","endTime":"0","summary":"励晶太平洋集团有限公司于2026年6月2日发布截至2026年5月31日止的证券变动月报表。报告显示，公司普通股法定/注册股份数量为143,000,000,000股，每股面值0.001美元，折合法定/注册股本共计143,000,000美元；另有550,000,000股未分类股份，每股面值0.001美元，对应法定/注册股本550,000美元。截至报告期末，公司法定/注册股本合计143,550,000美元，与上期持平。截至2026年5月31日，公司普通股已发行股份总数为291,815,782股，另无库藏股份，均未发生变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132100642","title":"励晶太平洋拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1132100642","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132100642?lang=zh_cn&edition=full","pubTime":"2026-05-06 21:02","pubTimestamp":1778072551,"startTime":"0","endTime":"0","summary":"励晶太平洋集团有限公司发布公告，董事会获授一项一般授权，可在公开市场购回不超过公司于授权当日已发行股份总数10%的股份。以公司当前已发行股份总数291,815,782股计算，最多可回购不超过29,181,578股。公告显示，过去12个月，励晶太平洋最高收市价曾达1.20港元/股，最低收市价为0.415港元/股。公司将在2026年5月29日举行股东周年大会，就上述回购授权等事宜进行表决。会议记录日期自2026年5月26日至5月29日止，公司将暂停办理股份过户登记。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"励晶太平洋拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632750932","title":"励晶太平洋(00575)建议采纳受限制股份单位计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2632750932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632750932?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:46","pubTimestamp":1777891602,"startTime":"0","endTime":"0","summary":"智通财经APP讯，励晶太平洋(00575)发布公告，于2026年5月4日，励晶太平洋集团有限公司(本公司，连同其附属公司统称“本集团”)董事会议决，建议本公司采纳受限制股份单位计划，目的是认可及奖励若干合资格参与者对本集团的增长及发展所作出的贡献，并为本集团的持续运营及发展，对其作出激励，以挽留相关人才，以及为本集团的进一步发展吸引合适的人才。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437899.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170404612","title":"励晶太平洋2026年4月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1170404612","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170404612?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:22","pubTimestamp":1777890126,"startTime":"0","endTime":"0","summary":"励晶太平洋集团有限公司于2026年5月4日发布股份变动月报表，披露截至2026年4月30日止期间的股本结构与发行情况。根据报告显示，公司整体股本在本月没有发生新增发行或回购注销变动。报告称，截至4月30日，已发行股份总数为291,815,782股，较上月底无变化，库存股份数量亦保持为零，公司确认已符合香港联交所的公众持股量要求。公司公告指出，其已遵守香港联交所《上市规则》及其他适用法律法规，并保持股本整体稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00575"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.Regentpac.com","stockEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":-0.1105},{"period":"3month","weight":0.4569},{"period":"6month","weight":-0.0611},{"period":"1year","weight":0.1267},{"period":"ytd","weight":-0.2103}],"compareEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":-0.0272},{"period":"3month","weight":0.0096},{"period":"6month","weight":-0.0201},{"period":"1year","weight":-0.0475},{"period":"ytd","weight":-0.0264}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"励晶太平洋集团有限公司（原名：寿康集团有限公司）是一家主要从事生物医药及投资业务的投资控股公司。该公司通过两个分部运营业务。生物医药分部主要从事生物医药产品的研究、开发、制造、推广及销售业务。企业投资分部主要从事上市及非上市公司投资业务。该公司还从事衰老研究及开发衰老研究相关的人工智能模型和工具产品。其向长寿诊所、预防医学组织、健康俱乐部、保险公司和老化研究机构提供老化和长寿时钟。","yearOnYearQuotes":[{"month":1,"riseRate":0.482759,"avgChangeRate":0.013636},{"month":2,"riseRate":0.482759,"avgChangeRate":0.025922},{"month":3,"riseRate":0.275862,"avgChangeRate":-0.054908},{"month":4,"riseRate":0.517241,"avgChangeRate":0.093095},{"month":5,"riseRate":0.517241,"avgChangeRate":0.066291},{"month":6,"riseRate":0.366667,"avgChangeRate":0.000576},{"month":7,"riseRate":0.3,"avgChangeRate":-0.021032},{"month":8,"riseRate":0.4,"avgChangeRate":-0.039151},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.037754},{"month":10,"riseRate":0.482759,"avgChangeRate":0.048501},{"month":11,"riseRate":0.482759,"avgChangeRate":0.035531},{"month":12,"riseRate":0.448276,"avgChangeRate":0.011323}],"exchange":"SEHK","name":"励晶太平洋","nameEN":"REGENT PACIFIC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"励晶太平洋(00575)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供励晶太平洋(00575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"励晶太平洋,00575,励晶太平洋股票,励晶太平洋股票老虎,励晶太平洋股票老虎国际,励晶太平洋行情,励晶太平洋股票行情,励晶太平洋股价,励晶太平洋股市,励晶太平洋股票价格,励晶太平洋股票交易,励晶太平洋股票购买,励晶太平洋股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"励晶太平洋(00575)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供励晶太平洋(00575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}